Company intelligence / Profile preview

TaiHao Medical

Taipei City, Taipei City, Taiwantaihaomed.com ↗

Ownership: Private
Development stage: Other

Overview

TaiHao Medical’s AI-powered medical imaging solutions have demonstrated a 40% reduction in diagnosis time and a 9.4% improvement in diagnostic accuracy for breast ultrasound. Their products are validated by regulatory agencies including the US FDA, Japan PMDA, Taiwan TFDA, Korea MFDS, and China NMPA.

Therapeutic areas: PulmonologyOncology
Modalities: Device (medical imaging software)Artificial intelligence-based diagnostic support systems
Industry: Medical Imaging

Partnerships

Government health screening programs in AsiaWomen’s breast centers/mammography clinicsInsurance companiesUltrasound machine manufacturers [e.g., integration with SIEMENS & GE ABUS images]

Beyond the preview

Go deeper on TaiHao Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TaiHao Medical.

Explore the full profile